HEC-96719 | m-entrepreneurship.com

Product Name :
HEC-96719

Search keywords :
HEC96719

drugId :
null

Target Vo:
Bile acid receptor FXR

Target Vo Short Name :
FXR

Moa_Name:
Bile acid receptor FXR agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Guangdong Dongyangguang Pharmaceutical Co Ltd

Active Company_Name :
Guangdong Dongyangguang Pharmaceutical Co Ltd

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-p95/NBS1 (S343)Rabbit mAb manufacturer
BRAF (YP5013) Mouse mAb site
Phospho-Smad3 (Ser423/425) Antibody: Phospho-Smad3 (Ser423/425) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-Smad3 (Ser423/425). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts